What Is MIS-C in Kids? A Plain-Language Guide to the Rare Condition Linked to COVID-19
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer: Key Facts About MIS-C
MIS-C is a rare, serious condition in which a child's immune system overreacts to COVID-19, causing bodywide inflammation, usually within two months of infection. Signs include fever for 4 to 6 days, rash, red eyes, belly pain and heart problems. Call 911 for trouble breathing, chest pain or confusion. Vaccination may help prevent it. [1]
Question | Answer |
What it is | A rare, serious condition where a child's immune system reacts too strongly to COVID-19, causing bodywide inflammation. |
When it happens | Usually within two months after a child has COVID-19 or was around someone who had it; most often in children ages 5 to 12. |
What it looks like | Fever for 4 to 6 days, rash, red eyes, red or swollen lips and tongue, swollen hands or feet, belly pain, vomiting, diarrhea, and heart problems. |
When it's an emergency | Severe belly pain, chest pain or pressure, trouble breathing, gray or blue skin or lips, new confusion, or trouble staying awake — call 911 right away. |
How it can be prevented | The COVID-19 vaccine may help prevent MIS-C, along with masking, ventilation, hand hygiene, and avoiding sick people when cases are high in your area. |
What the research says
Two doses of the Pfizer-BioNTech vaccine strongly protected teens against MIS-C. In a US test-negative case-control study at 24 pediatric hospitals (102 teens with MIS-C and 181 hospitalized controls aged 12–18, during Delta variant predominance), two doses received at least 28 days before admission were 91% effective against MIS-C (95% CI 78%–97%). All 38 patients with MIS-C who needed life support were unvaccinated. (Zambrano et al., MMWR, 2022) [7]
MIS-C often needs intensive care, but heart problems usually improve. In a JAMA case series of 1,116 US children and adolescents (539 with MIS-C), 73.8% of those with MIS-C were admitted to intensive care and 1.9% died during hospitalization. Among those with reduced left ventricular function (34.2%) and coronary artery aneurysm (13.4%), an estimated 91.0% and 79.1%, respectively, returned to normal within 30 days. (Feldstein et al., JAMA, 2021) [8]
What Is MIS-C?
Multisystem inflammatory syndrome in children — called MIS-C for short — is a rare but serious illness linked to coronavirus disease 2019 (COVID-19). [1]
Most children with COVID-19 have only mild illness. But with MIS-C, the body's immune system reacts too strongly. Instead of just fighting the virus, the overreaction causes damage to the body. [1]
MIS-C usually happens within two months after a child has had COVID-19 or has been around someone who had the illness. Most children with MIS-C get better over time, but some kids quickly get worse. MIS-C can be a life-threatening illness and, sometimes, causes death. [1]
What's the Difference Between MIS-C and Normal COVID-19 in Kids?
In most children, COVID-19 causes mild illness. In MIS-C, the problem isn't the virus itself — it's the immune system's response. The immune system reacts too strongly and injures the body's own organs. [1]
Here is a simple way to picture it: with mild COVID-19, the immune system fights the virus and calms down. With MIS-C, the immune system stays switched "on" far too hard and far too long, causing inflammation across several organ systems at once.

What Are the Symptoms of MIS-C?
MIS-C causes serious symptoms that are often treated in the hospital. Not all children have the same symptoms. [1]
If no other diagnosis fits, healthcare professionals may diagnose MIS-C when a child meets four conditions: [1]
Examples of symptoms in other organ systems include:
Organ system | Possible symptoms |
Heart | |
Skin and eyes | |
Digestive system | |
Blood | Blood test results outside the reference range — for example, too many immune cells or too few platelets (the blood cells that help clotting) [1] |
Whole body | Shock — a bodywide response to the immune system that affects blood vessels and the heart [1] |

When Should I Call 911?
Call 911 or your local emergency number right away if your child shows any emergency warning signs of MIS-C. [1]
Emergency warning sign | What to watch for |
Severe belly pain | Severe belly pain [1] |
Chest pain or pressure | Pain or a feeling of pressure in the chest [1] |
Breathing problems | Trouble breathing [1] |
Skin color changes | Gray or blue skin, lips, or nail beds [1] |
New confusion | Sudden confusion or not making sense [1] |
Extreme sleepiness | Trouble waking up or staying awake [1] |

When Should I See a Doctor?
Get care right away if your child has severe belly pain, pain or pressure in the chest, trouble breathing, new confusion, or trouble waking up or staying awake. Take your child to the nearest emergency room or call 911 or your local emergency number. [1]
If your child isn't severely ill but has symptoms of MIS-C, contact your child's healthcare professional right away for advice. [1]
What Causes MIS-C?
The exact cause of MIS-C is not known. Many children with MIS-C have had a recent infection with the COVID-19 virus. Some may have a current infection with the virus. [1]
Who Is at Higher Risk?
MIS-C most often affects children ages 5 to 12. Older and younger kids can get MIS-C, but it's rare. [1]
Can MIS-C Cause Long-Term Problems?
MIS-C is a possible complication of COVID-19. Without quick diagnosis and treatment, MIS-C can cause serious symptoms in vital organs, such as the heart. Rarely, MIS-C may cause lasting health issues or death. [1]
That is why fast action matters: most children with MIS-C get better over time, but some kids quickly get worse. [1]
Can MIS-C Be Prevented?
Getting a COVID-19 vaccine may help prevent MIS-C. [1] Four COVID-19 vaccines are FDA-approved in the United States for the 2026–2027 season, all updated to target the XFG variant. Each is approved by age, and for people younger than 65 the approvals cover those with at least one underlying condition that raises the risk of severe COVID-19. [5] [6]
Vaccine | Age range | Key detail |
Spikevax (Moderna) | 6 months and older [5] | |
Comirnaty XFG (Pfizer-BioNTech) | 5 years and older [5] | |
mNEXSPIKE (Moderna) | 12 years and older [5] | |
Nuvaxovid (Novavax) | 12 years and older [5] | Approved for adults 65 and older and for younger people at higher risk; the only non-mRNA option [5] |
Here is what else to know about vaccination:
COVID-19 vaccines protect against serious illness and the need for hospital care due to COVID-19. Serious side effects from the COVID-19 vaccine are extremely rare. [1]
The American Academy of Pediatrics' 2026–2027 recommendations call for the 2026–2027 COVID-19 vaccine for all infants and children aged 6 through 23 months who have no contraindications, and a single dose for children aged 2 through 18 years who are not considered at risk of severe COVID-19 if a parent or guardian wants their protection. Children at higher risk have separate recommendations. [3] [4]
Dose schedules are updated each season. Ask your child's healthcare professional which doses your child needs.
The COVID-19 vaccine can be given to children on the same day as other vaccines if the timing is correct. [1]
How Can I Help Control the Spread?
If many people in your area have COVID-19, a few steps can help control the spread of the virus: [1]
Prevention step | Details |
Wear a mask indoors | Wear a well-fitting mask indoors in public places when COVID-19 is spreading in your area. Never put a mask on a child younger than age 2 or a child with a disability who can't safely wear one [1] |
Move the air | Open windows or doors, use fans, and use air filters to help clean the air [1] |
Keep your distance | Stay apart from anyone who is sick or has symptoms; spread out in crowded indoor spaces, especially where airflow is poor [1] |
Clean often | Keep hands clean, and regularly clean and disinfect your home [1] |
What is the bottom line on MIS-C in kids?
MIS-C is a rare but serious condition where a child's immune system reacts too strongly after COVID-19, causing inflammation that can hurt the heart, skin, eyes, digestive system, and more. It most often affects children ages 5 to 12 and usually shows up within two months of a COVID-19 infection or exposure. The good news: most children get better over time. The urgent news: the warning signs — severe belly pain, chest pain or pressure, breathing trouble, gray or blue skin, new confusion, and trouble staying awake — mean you should call 911 right away. COVID-19 vaccination may help prevent MIS-C, and simple steps like masking, fresh air, and hand hygiene help control the spread. [1]
Take the Next Step
If your child recently had COVID-19 or was around someone who did, and now has a fever lasting several days plus rash, red eyes, belly pain, or unusual tiredness, don't wait it out. Contact your child's healthcare professional right away — and call 911 for any of the six emergency warning signs. Rinnit.com's plain-language guides help you understand what each warning sign means, what the diagnosis process looks like, and what questions to ask at your appointment, so you can act fast and feel prepared.
If your child hasn't had a COVID-19 vaccine yet, ask your pediatrician whether the 2026–2027 vaccine is right for their age and health — vaccination may help prevent MIS-C, and serious side effects are extremely rare.
Frequently Asked Questions
What is MIS-C in simple terms?
MIS-C (multisystem inflammatory syndrome in children) is a rare, serious condition linked to COVID-19 where the immune system reacts too strongly and damages the body instead of just fighting the virus. [1]
How soon after COVID-19 does MIS-C appear?
MIS-C usually happens within two months after a child has had COVID-19 or has been around someone who had the illness. [1]
Which children are most at risk for MIS-C?
MIS-C most often affects children ages 5 to 12. Older and younger kids can get it, but it's rare. [1]
What are the main symptoms of MIS-C?
Symptoms can include a fever lasting 4 to 6 days, rash, red eyes, red or swollen lips or tongue, swollen hands or feet, belly pain, vomiting, diarrhea, and problems with how the heart pumps blood. Blood tests often show a high level of inflammation. [1]
When should I call 911 for a child with possible MIS-C?
Call 911 right away for severe belly pain, chest pain or pressure, trouble breathing, gray or blue skin or lips or nail beds, new confusion, or trouble waking up or staying awake. [1]
What causes MIS-C?
The exact cause is not known, but many children with MIS-C have had a recent COVID-19 infection, and some have a current infection. [1]
Can my child get better after MIS-C?
Yes. Most children with MIS-C get better over time. However, some kids quickly get worse, and without quick diagnosis and treatment the condition can cause serious problems in vital organs such as the heart — and rarely, lasting health issues or death. [1]
Can vaccination help prevent MIS-C?
Getting a COVID-19 vaccine may help prevent MIS-C. [1] Four vaccines (Spikevax, Comirnaty XFG, mNEXSPIKE, and Nuvaxovid) are FDA-approved for the 2026–2027 season by age and health status, and serious side effects are extremely rare. [1] [5] Masking, ventilation, distancing, and hand hygiene also help control the spread. [1]
Related Reading
Read next on Rinnit.com:
References
Mayo Clinic Staff. Multisystem inflammatory syndrome in children (MIS-C) and COVID-19 - Symptoms & causes. Mayo Clinic. August 31, 2026. https://www.mayoclinic.org/diseases-conditions/mis-c-in-kids-covid-19/symptoms-causes/syc-20502550
Centers for Disease Control and Prevention. Case Definitions and Reporting. CDC. February 19, 2026. https://www.cdc.gov/mis/hcp/case-definition-reporting/
American Academy of Pediatrics. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement. Pediatrics. 2026. PMID 42683684. https://doi.org/10.1542/peds.2026-079045
Guideline Central. 2026 AAP COVID-19 Vaccines in Infants, Children, and Adolescents 2026-2027 Statement Now Available. Guideline Central. September 5, 2026. https://www.guidelinecentral.com/insights/sep-2026-aap-covid19infantschildrenadolescents-guideline-spotlight/
Epocrates. Four FDA-approved COVID vaccines for the 2026–27 season. Epocrates. August 31, 2026. https://www.epocrates.com/online/article/four-fda-approved-covid-vaccines-for-the-2026-27-season
Contagion Live. FDA Approves Multiple COVID-19 Vaccines With Protection Against XFG variant. Contagion Live. August 28, 2026. https://www.contagionlive.com/view/fda-approves-3-covid-19-vaccines-with-protection-against-xfg-variant
Zambrano LD, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52-58. PMID 35025852. https://doi.org/10.15585/mmwr.mm7102e1
Feldstein LR, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325(11):1074-1087. PMID 33625505. https://doi.org/10.1001/jama.2021.2091
Medical disclaimer
This article is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment decisions. In an emergency, call 911 or your local emergency number.




Comments